Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06658353 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

StatusRecruiting
PhasePhase 3
Started2025-03-17
View on ClinicalTrials.gov ↗

Amendment history

2026-07-23
Study Status v2
Re-verified, no change to tracked fields
2025-03-18
Not Yet Recruiting→Recruiting Study Status, Study Design, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-11-20→confirmed 2025-03-17
Study sitesdetails revised at 1 of 1 site
2024-10-24
Original filing
This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.
Trial Details
NCT Number NCT06658353
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Locally Advanced Solid Tumor
Enrollment 54 participants
Start Date 2025-03-17
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-27